sorafenib has been researched along with 3,4-methylenedioxyamphetamine in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (3,4-methylenedioxyamphetamine) | Trials (3,4-methylenedioxyamphetamine) | Recent Studies (post-2010) (3,4-methylenedioxyamphetamine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 4,806 | 77 | 1,373 |
| Protein | Taxonomy | sorafenib (IC50) | 3,4-methylenedioxyamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.2314 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.7129 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.996 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.6486 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, N; Lan, H; Li, H; Yi, C; Zhang, M; Zhao, F | 1 |
1 other study(ies) available for sorafenib and 3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells.
Topics: 3,4-Methylenedioxyamphetamine; Carcinoma, Hepatocellular; Ferroptosis; Humans; Liver Neoplasms; Reactive Oxygen Species; Sorafenib; TEA Domain Transcription Factors | 2023 |